Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310000 Hangzhou, Zhejiang Province, China.
Department of Pathology, Taizhou Hospital of Zhejiang Province affliated to Wenzhou Medical University, 318000 Taizhou, Zhejiang Province, China.
Ann Diagn Pathol. 2024 Oct;72:152325. doi: 10.1016/j.anndiagpath.2024.152325. Epub 2024 May 8.
Primary mucinous tumors of the renal pelvis are extremely rare and pose challenges in terms of diagnosis and treatment. This study reviewed the clinical and pathological characteristics of mucinous tumors of the renal pelvis, including mucinous cystadenocarcinomas and mucinous cystadenomas. Immunohistochemical analysis was conducted in three cases, along with KRAS gene detection using the Amplification Refractory Mutation System (ARMS) method. The results revealed mucinous epithelium with acellular mucinous pools in all cases, and acellular mucinous pools were observed in the renal parenchyma and perirenal fat capsules. All tumors expressed CK20 and CDX2, and one case showed KRAS gene mutation. The study suggests that mucinous cystadenomas of the renal pelvis may exhibit borderline biological behaviors. This study is the first to report a KRAS gene mutation in a mucinous cystadenoma of the renal pelvis, offering valuable insights into the diagnosis and treatment of this rare condition.
肾盂原发性黏液性肿瘤极其罕见,在诊断和治疗方面具有挑战性。本研究回顾了肾盂黏液性肿瘤(包括黏液囊腺癌和黏液囊腺瘤)的临床和病理特征。对 3 例患者进行了免疫组织化学分析,并采用扩增阻滞突变系统(ARMS)法检测了 KRAS 基因。结果显示,所有病例均有细胞外黏液池的黏液上皮,肾实质和肾周脂肪囊内可见细胞外黏液池。所有肿瘤均表达 CK20 和 CDX2,1 例存在 KRAS 基因突变。研究提示肾盂黏液囊腺瘤可能具有交界性生物学行为。本研究首次报道了肾盂黏液囊腺瘤的 KRAS 基因突变,为该罕见疾病的诊断和治疗提供了有价值的信息。